Pages that link to "Q41195761"
Jump to navigation
Jump to search
The following pages link to Regulation of CTLA-4 expression during T cell activation (Q41195761):
Displaying 50 items.
- The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future (Q24673258) (← links)
- Cell Type-Specific Regulation of Immunological Synapse Dynamics by B7 Ligand Recognition (Q26766419) (← links)
- Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade (Q26769977) (← links)
- CD28 and CTLA-4 coreceptor expression and signal transduction (Q28244243) (← links)
- CTLA-4 trafficking and surface expression (Q28279561) (← links)
- Immune Modulation through 4-1BB Enhances SIV Vaccine Protection in Non-Human Primates against SIVmac251 Challenge (Q28740359) (← links)
- Biochemical analysis of CTLA-4 immunoreactive material from human blood (Q33505854) (← links)
- Checkpoint inhibitors in hematological malignancies (Q33651495) (← links)
- Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. (Q33667690) (← links)
- Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function (Q33733354) (← links)
- Foxo transcription factors control regulatory T cell development and function (Q33774905) (← links)
- Influence of molecular genetics in Vogt-Koyanagi-Harada disease. (Q33929571) (← links)
- Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4. (Q34001979) (← links)
- CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response (Q34007765) (← links)
- Anti-CTLA-4 treatment induces IL-10-producing ICOS regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis (Q34048386) (← links)
- T cells and lung injury. Impact of rapamycin. (Q34103700) (← links)
- The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes (Q34647086) (← links)
- Alternative splicing in multiple sclerosis and other autoimmune diseases (Q34762634) (← links)
- Differential CTLA-4 expression in human CD4 versus CD8 T cells is associated with increased NFAT1 and inhibition of CD4 proliferation. (Q34824109) (← links)
- Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter (Q34907715) (← links)
- CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors (Q35101747) (← links)
- Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity (Q35633382) (← links)
- Loss of immunological tolerance in Gimap5-deficient mice is associated with loss of Foxo in CD4 T cells (Q35673283) (← links)
- Costimulation: critical pathways in the immunologic regulation of asthma (Q36026037) (← links)
- Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome (Q36085054) (← links)
- Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule. (Q36404652) (← links)
- Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP. (Q36539552) (← links)
- Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase‐deficient mouse model of human hyper‐IgD syndrome (HIDS) (Q36845648) (← links)
- At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy (Q36935749) (← links)
- Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. (Q36973929) (← links)
- CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance (Q37157989) (← links)
- Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model (Q37362097) (← links)
- Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement (Q37522254) (← links)
- Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease (Q37782273) (← links)
- Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family (Q37864700) (← links)
- Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4. (Q38299845) (← links)
- Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy (Q38636569) (← links)
- Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers (Q38974499) (← links)
- Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis (Q39215639) (← links)
- Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation (Q39321597) (← links)
- Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier (Q41078784) (← links)
- Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Interferes with Extracellular Signal-regulated Kinase (ERK) and Jun NH2-terminal Kinase (JNK) Activation, but Does Not Affect Phosphorylation of T Cell Receptor ζ and ZAP70 (Q41909802) (← links)
- Foxp1 Negatively Regulates T Follicular Helper Cell Differentiation and Germinal Center Responses by Controlling Cell Migration and CTLA-4. (Q48165191) (← links)
- The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis (Q50119256) (← links)
- NKG2H-Expressing T Cells Negatively Regulate Immune Responses. (Q52653107) (← links)
- Current treatment options for psoriatic arthritis: spotlight on abatacept. (Q55318901) (← links)
- Immunotherapies: Exploiting the Immune System for Cancer Treatment. (Q55362851) (← links)
- Endocrine toxicity of cancer immunotherapy targeting immune checkpoints (Q56889222) (← links)
- Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4 (Q56889385) (← links)
- The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children (Q56902043) (← links)